Found vs Invigor Medical
Two GLP-1 desks, one scoreboard. We put Found and Invigor Medical head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.
The verdict
Too close to call on the Brief Score.
Found and Invigor Medical are level at 88/100. The scores won't separate them, so the pick comes down to fit: Found for readers who want behavior-change coaching bundled with medication at the lowest tracked identical rate. Invigor Medical for readers who want glp-1 care alongside a wider wellness/hormone program.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Found | Invigor Medical | |
|---|---|---|
| Brief Score | 88/100 (B+) | 88/100 (B+) |
| Semaglutide | $129/mo | $199/mo |
| Tirzepatide | $129/mo | $339/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Found: Lowest identical-price line on the board — but bundled into a coaching subscription.
Invigor Medical: Long-running operator; mid-market pricing unchanged this cycle.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.